Study Evaluating the Efficacy and Safety of CM336 Injection in the Treatment of Light-Chain Amyloidosis

Clinical trial NCT07039578 · RECRUITING

Trial details

NCT number: NCT07039578
Sponsor: Keymed Biosciences Co.Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Light-Chain Amyloidosis

Start date: 2025-07-25
Primary completion: 2026-06-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.